INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAC2. A total of 7 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 98,354,000 | $101,202,725 | 2.26% |
| Graham Capital Management, L.P. | 4,500,000 | $4,668,750 | 0.14% |
| WOLVERINE ASSET MANAGEMENT LLC | 7,792,000 | $8,092,917 | 0.10% |
| CITIGROUP INC | 262,000 | $270,353 | 0.00% |
| JPMORGAN CHASE & CO | 175,000 | $181,000 | 0.00% |
| JANE STREET GROUP, LLC | 60,000 | $61,662 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |